← Leaderboards
Donald R Senger
Beth Israel Deaconess Medical Center
$6,635,477
Attributed
$6,635,477
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $850.4K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,635,477 · 5
By mechanism
R01$6,161,665 · 4
R21$473,812 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Laura E Benjamin$10,185,711
- Frank W Sellke$18,106,428
- Anny A Usheva-Simidjiyska$6,725,063
- Francine K Welty$7,046,001
- Harold Fisher Dvorak$13,877,917
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisVascular Endothelial Growth FactorsBlood VesselsSignal PathwayDesignEndothelial CellsMouse ModelArchitectureMorphogenesisResponseDefectHypoxiaCalpainBlood FlowCytoskeletonResearch StudyOxygenRho Gtp-Binding ProteinsPeptide HydrolasesPerfusionIntegrinsGuanosine Triphosphate PhosphohydrolasesPharmaceutical PreparationsClinical Research
Grant awards (20)
Remedying dysfunctional angiogenesis and tissue ischemia with Barleria lupulina$475,492
R01 · FY2015 · AT · contact PI
Remedying dysfunctional angiogenesis and tissue ischemia with Barleria lupulina$475,492
R01 · FY2014 · AT · contact PI
Remedying dysfunctional angiogenesis and tissue ischemia with Barleria lupulina$475,070
R01 · FY2013 · AT · contact PI
Remedying dysfunctional angiogenesis and tissue ischemia with Barleria lupulina$508,264
R01 · FY2012 · AT · contact PI
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies$342,168
R01 · FY2012 · CA · contact PI
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies$342,168
R01 · FY2011 · CA · contact PI
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies$352,750
R01 · FY2010 · CA · contact PI
Regulation of Vascular Morphogenesis in Adult Brain$206,270
R21 · FY2010 · NS · contact PI
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies$352,750
R01 · FY2009 · CA · contact PI
Regulation of Vascular Morphogenesis in Adult Brain$267,542
R21 · FY2009 · NS · contact PI
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies$352,750
R01 · FY2008 · CA · contact PI
Antagonism of VEGF-Driven Angiogenesis$303,039
R01 · FY2007 · CA · contact PI
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS$312,089
R01 · FY2006 · CA · contact PI
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS$319,600
R01 · FY2005 · CA
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS$319,600
R01 · FY2004 · CA
ANTAGONISM OF VEGF-DRIVEN ANGIOGENESIS$319,600
R01 · FY2003 · CA
ANTAGONISM OF VEGF DRIVEN ANGIOGENESIS$277,163
R01 · FY2001 · CA
BETA 1 INTEGRIN ANTAGONISM &RETINAL NEOVASCULARIZATION$175,073
R01 · FY2001 · EY
ANTAGONISM OF VEGF DRIVEN ANGIOGENESIS$269,093
R01 · FY2000 · CA
BETA 1 INTEGRIN ANTAGONISM &RETINAL NEOVASCULARIZATION$189,504
R01 · FY2000 · EY